STOCKWATCH
·
Pharmaceuticals
Joint Venture3 Apr 2026, 07:44 pm

Senores Pharmaceuticals Forms Joint Venture Company 'Amerisyn, LLC' in the USA

AI Summary

Senores Pharmaceuticals Limited has formed a joint venture company named Amerisyn, LLC in the state of North Carolina, USA through its wholly owned subsidiary, Senores Pharmaceuticals, Inc., USA. The joint venture company has been formed with an Operating Agreement dated April 02, 2026. Senores Pharmaceuticals, Inc., USA has subscribed to 70% of the membership interest in Amerisyn, LLC, making it a step-down subsidiary of Senores Pharmaceuticals Limited.

Key Highlights

  • Senores Pharmaceuticals Limited forms a joint venture company named Amerisyn, LLC in the USA
  • The joint venture company has been formed through the wholly owned subsidiary of Senores Pharmaceuticals Limited, Senores Pharmaceuticals, Inc., USA
  • Senores Pharmaceuticals, Inc., USA has subscribed to 70% of the membership interest in Amerisyn, LLC
  • Amerisyn, LLC has become a step-down subsidiary of Senores Pharmaceuticals Limited
  • The joint venture company has been formed with an Operating Agreement dated April 02, 2026
SENORES
Pharmaceuticals
Senores Pharmaceuticals Ltd

Price Impact